BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18028428)

  • 1. Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma.
    Kastrup IB; Worm J; Ralfkiaer E; Hokland P; Guldberg P; Grønbaek K
    Eur J Haematol; 2008 Jan; 80(1):61-6. PubMed ID: 18028428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
    Ferreri AJ; Dell'Oro S; Capello D; Ponzoni M; Iuzzolino P; Rossi D; Pasini F; Ambrosetti A; Orvieto E; Ferrarese F; Arrigoni G; Foppoli M; Reni M; Gaidano G
    Br J Haematol; 2004 Sep; 126(5):657-64. PubMed ID: 15327516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
    Kaufman Y; Drori S; Cole PD; Kamen BA; Sirota J; Ifergan I; Arush MW; Elhasid R; Sahar D; Kaspers GJ; Jansen G; Matherly LH; Rechavi G; Toren A; Assaraf YG
    Cancer; 2004 Feb; 100(4):773-82. PubMed ID: 14770434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases.
    Al-Kuraya KS; Siraj AK; Al-Dayel FA; Ezzat AA; Al-Jommah NA; Atizado VL; Narayanappa RN
    Saudi Med J; 2005 Jul; 26(7):1099-103. PubMed ID: 16047061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-amino-4-imidazolecarboxamide riboside potentiates both transport of reduced folates and antifolates by the human reduced folate carrier and their subsequent metabolism.
    McGuire JJ; Haile WH; Yeh CC
    Cancer Res; 2006 Apr; 66(7):3836-44. PubMed ID: 16585211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
    Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
    Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.
    Yang R; Sowers R; Mazza B; Healey JH; Huvos A; Grier H; Bernstein M; Beardsley GP; Krailo MD; Devidas M; Bertino JR; Meyers PA; Gorlick R
    Clin Cancer Res; 2003 Feb; 9(2):837-44. PubMed ID: 12576457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity.
    Ifergan I; Meller I; Issakov J; Assaraf YG
    Cancer; 2003 Nov; 98(9):1958-66. PubMed ID: 14584080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
    Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
    Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of methotrexate resistance in osteosarcoma.
    Guo W; Healey JH; Meyers PA; Ladanyi M; Huvos AG; Bertino JR; Gorlick R
    Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense mutation with/without nonsense mutation of the p53 gene is associated with large cell morphology in human malignant lymphoma.
    Mitani S; Kamata H; Fujiwara M; Aoki N; Okada S; Watanabe M; Tango T; Mori S
    Pathol Int; 2007 Jul; 57(7):430-6. PubMed ID: 17587242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.
    Ma D; Huang H; Moscow JA
    Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
    Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
    Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifolate resistance in a HeLa cell line associated with impaired transport independent of the reduced folate carrier.
    Zhao R; Chattopadhyay S; Hanscom M; Goldman ID
    Clin Cancer Res; 2004 Dec; 10(24):8735-42. PubMed ID: 15623659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
    Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
    Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
    Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
    Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of the bone morphogenetic protein-6 gene in malignant lymphoma.
    Daibata M; Nemoto Y; Bandobashi K; Kotani N; Kuroda M; Tsuchiya M; Okuda H; Takakuwa T; Imai S; Shuin T; Taguchi H
    Clin Cancer Res; 2007 Jun; 13(12):3528-35. PubMed ID: 17575215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
    Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C
    J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel BLIMP1/PRDM1 gene mutations in B-cell lymphoma.
    Tate G; Hirayama-Ohashi Y; Kishimoto K; Mitsuya T
    Cancer Genet Cytogenet; 2007 Jan; 172(2):151-3. PubMed ID: 17213024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.
    Gorlick R; Goker E; Trippett T; Steinherz P; Elisseyeff Y; Mazumdar M; Flintoff WF; Bertino JR
    Blood; 1997 Feb; 89(3):1013-8. PubMed ID: 9028333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.